Evidence map›Paper›PMID 29736827›Full record

ArticleNeurotoxicity research2018

Generalized Anxiety Disorder (GAD) and Comorbid Major Depression with GAD Are Characterized by Enhanced Nitro-oxidative Stress, Increased Lipid Peroxidation, and Lowered Lipid-Associated Antioxidant Defenses.

Michael Maes, Kamila Landucci Bonifacio, Nayara Rampazzo Morelli, Heber Odebrecht Vargas, Estefânia Gastaldello Moreira, Drozdstoy St Stoyanov, Décio Sabbatini Barbosa, André F Carvalho, Sandra Odebrecht Vargas Nunes

Abstract read
PubMed Publisher
In one paragraph

Article in Neurotoxicity research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Serum Levels of 8-Iso-Prostaglandin F2α and Raftlin in Patients with Generalized Anxiety Disorder.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 5 countries.

Michael MaesHealth Sciences Graduation Program, Health Sciences Center, State University of Londrina, Londrina, Parana, Brazil. dr.michaelmaes@hotmail.com.ORCID http://orcid.org/0000-0002-2012-871X
Kamila Landucci BonifacioHealth Sciences Graduation Program, Health Sciences Center, State University of Londrina, Londrina, Parana, Brazil.
Nayara Rampazzo MorelliHealth Sciences Graduation Program, Health Sciences Center, State University of Londrina, Londrina, Parana, Brazil.
Heber Odebrecht VargasHealth Sciences Graduation Program, Health Sciences Center, State University of Londrina, Londrina, Parana, Brazil.
Estefânia Gastaldello MoreiraHealth Sciences Graduation Program, Health Sciences Center, State University of Londrina, Londrina, Parana, Brazil.
Drozdstoy St StoyanovDepartment of Psychiatry, Medical University of Plovdiv and Technological Center for Emergency Medicine, Plovdiv, Bulgaria.
Décio Sabbatini BarbosaHealth Sciences Graduation Program, Health Sciences Center, State University of Londrina, Londrina, Parana, Brazil.
André F CarvalhoDepartment of Psychiatry, University of Toronto, Toronto, ON, Canada.
Sandra Odebrecht Vargas NunesHealth Sciences Graduation Program, Health Sciences Center, State University of Londrina, Londrina, Parana, Brazil.
Universidade Estadual de Londrina · BRCentre for Addiction and Mental Health · CAMedical University Plovdiv · BG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidence shows that nitro-oxidative pathways play an important role in the pathophysiology of major depressive disorder (MDD) and bipolar disorder (BD) and maybe anxiety disorders. The current study aims to examine superoxide dismutase (SOD1), catalase, lipid hydroperoxides (LOOH), nitric oxide metabolites (NOx), advanced oxidation protein products (AOPP), malondialdehyde (MDA), glutathione (GSH), paraoxonase 1 (PON1), high-density lipoprotein cholesterol (HDL), and uric acid (UA) in participants with and without generalized anxiety disorder (GAD) co-occurring or not with BD, MDD, or tobacco use disorder. Z unit-weighted composite scores were computed as indices of nitro-oxidative stress driving lipid and protein oxidation. SOD1, LOOH, NOx, and uric acid were significantly higher and HDL and PON1 significantly lower in participants with GAD than in those without GAD. GAD was more adequately predicted by increased SOD + LOOH + NOx and lowered HDL + PON1 composite scores. Composite scores of nitro-oxidative stress coupled with aldehyde and AOPP production were significantly increased in participants with comorbid GAD + MDD as compared with all other study groups, namely MDD, GAD + BD, BD, GAD, and healthy controls. In conclusion, GAD is characterized by increased nitro-oxidative stress and lipid peroxidation and lowered lipid-associated antioxidant defenses, while increased uric acid levels in GAD may protect against aldehyde production and protein oxidation. This study suggests that increased nitro-oxidative stress and especially increased SOD1 activity, NO production, and lipid peroxidation as well as lowered HDL-cholesterol and PON1 activity could be novel drug targets for GAD especially when comorbid with MDD.

Indexed as

AdultAdvanced Oxidation Protein ProductsAnalysis of VarianceAnxiety DisordersAryldialkylphosphataseBody Mass IndexFemaleHumansLipid PeroxidationLipoproteins, HDLMajor Depressive DisorderMaleMalondialdehydeMiddle AgedNitric OxideOxidative StressAdvanced Oxidation Protein ProductsAryldialkylphosphataseLipoproteins, HDLMalondialdehydeNitric OxideUric AcidBipolar disorderGeneralized anxiety disorderImmuneInflammationMajor depressive disorderOxidative and nitrosative stress

Identifiers

PMID29736827
OpenAlexW2801598945

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.